Atormac
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 2368  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3608    
    Printed160    
    Emailed5    
    PDF Downloaded86    
    Comments [Add]    
    Cited by others 4    

Recommend this journal

 

 CASE REPORT
Year : 2011  |  Volume : 59  |  Issue : 1  |  Page : 117--119

Primary telangiectatic osteosarcoma of occipital bone: A case report and review of literature


1 Department of Neurosurgery, Nizam's Institute of Medical Sciences, Hyderabad, India
2 Department of Pathology, Nizam's Institute of Medical Sciences, Hyderabad, India
3 Department of Neurosurgery, NRI Medical College, Mangalagiri, Hyderabad, India
4 Department of Neurosurgery, Krishna Institute of Medical Sciences, Hyderabad, India

Correspondence Address:
Manas K Panigrahi
Department of Neurosurgery, Krishna Institute of Medical Sciences, Hyderabad, Andhra Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.76891

Rights and Permissions

Telangiectatic osteosarcoma (TOS), an uncommon variant of osteosarcoma, involving skull bones is extremely rare. We present clinico-pathological, imageological and treatment outcome of a primary TOS of occipital bone in a 30-year-old woman and review the previously reported skull bone TOS. We suggest that TOS should be included in the differential diagnosis of destructive lytic lesions involving the skull bones. As radical surgical procedures are not applicable to skull bones, the outcome is poor even with adjuvant chemotherapy.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow